Literature DB >> 30132147

Endothelial dysfunction in patients with eosinophilic granulomatosis with polyangiitis.

Renata Pacholczak1,2, Stanisława Bazan-Socha3, Teresa Iwaniec3, Lech Zaręba4, Stan Kielczewski1, Jerzy Andrzej Walocha1, Jacek Musiał3, Jerzy Dropiński5.   

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare form of vasculitis associated with asthma and eosinophilia. Endothelial dysfunction has been well documented in other types of vasculitis but not in EGPA. Thirty patients (10 men and 20 women) diagnosed with EGPA and remaining in a remission, and 58 controls (24 men and 34 women) matched for age, sex, and body mass index, were enrolled in the study. We assessed each participants for typical risk factors of cardiovascular diseases and measured serum levels of vascular cell adhesion molecule-1 (VCAM-1), interleukin 6 (IL-6), and thrombomodulin. We also measured flow-mediated dilatation (FMD) of the brachial artery and intima-media thickness (IMT) of the common carotid artery using ultrasonography. Patients with EGPA had 20% higher serum level of VCAM-1 (p < 0.001) and 41.9% of thrombomodulin (p < 0.001). They also had 38.8% lower relative increase of FMD (FMD%) (p < 0.001), indicating endothelial dysfunction. These differences remained significant also after adjustment for potential confounders. Laboratory and ultrasonographic parameters of endothelial injury were correlated to the markers of inflammation and impaired kidney function. Determinants of lower FMD% in a simple regression model were pack-years of smoking (β = - 0.3 [95% confidence interval (CI) - 0.5 to - 0.1]), serum level of IL-6 (β = - 0.36 [95% CI - 0.62 to - 0.1]), and thrombomodulin (β = - 0.34 [95% CI - 0.6 to - 0.08]). EGPA patients are characterized by inflammatory endothelial injury that is likely related to the pathogenesis of the disease. Proper immunosuppressive treatment is the best method to prevent atherosclerosis and future cardiovascular events, the patients may also benefit from additional preventive interventions.

Entities:  

Keywords:  Atherosclerosis; Endothelium; Eosinophilic granulomatosis with polyangiitis; FMD

Mesh:

Substances:

Year:  2018        PMID: 30132147     DOI: 10.1007/s10067-018-4253-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  3 in total

Review 1.  Eosinophilic Vasculitis.

Authors:  Karen L Vega Villanueva; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2020-01-11       Impact factor: 4.592

2.  Endothelial dysfunction in patients with systemic sclerosis.

Authors:  Renata Pacholczak-Madej; Piotr Kuszmiersz; Stanisława Bazan-Socha; Joanna Kosałka-Wêgiel; Teresa Iwaniec; Lech Zarêba; Stan Kielczewski; Anna Rams; Jerzy A Walocha; Jacek Musiał; Jerzy Dropiñski
Journal:  Postepy Dermatol Alergol       Date:  2020-09-02       Impact factor: 1.837

3.  Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides.

Authors:  Camille Roubille; Soledad Henriquez; Cédric Mercuzot; Claire Duflos; Bertrand Dunogue; Karine Briot; Loic Guillevin; Benjamin Terrier; Pierre Fesler
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.